Shirota T, Oguchi N, Shinohara K, Noguchi Y, Ishii K, Takeichi M, Yamamoto H, Roppongi H, Hayashi T
Third Department of Internal Medicine, Tokyo Medical College Hospital, Japan.
Cancer Genet Cytogenet. 1998 Dec;107(2):144-6. doi: 10.1016/s0165-4608(98)00096-x.
A new variant translocation, (8;20)(q22;q13) in a patient with acute myelocytic leukemia (AML) M2 is reported. As far as we know, this is the second case of the t(8;20) in de novo AML. Further studies are required to clarify the key event leading to the development of AML-M2.